Similarly in the LIPGENE-SU.VI.MAX study rs7903146 was associated with increased MetS risk, arising from their impaired insulin sensitivity, greater insulin resistance, increased abdominal obesity and hypertension [60]. This evidence concerns the gene INS and Abdominal obesity.